Tauriga Sciences, Inc.
TAUG · OTC
3/31/2021 | 3/31/2020 | 3/31/2019 | 3/31/2018 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $50 | $5 | $386 | $12 |
| Short-Term Investments | $1,559 | $279 | $423 | $633 |
| Receivables | $32 | $43 | -$0 | $1 |
| Inventory | $647 | $129 | $11 | $0 |
| Other Curr. Assets | $109 | $152 | $128 | $41 |
| Total Curr. Assets | $2,397 | $608 | $948 | $686 |
| Property Plant & Equip (Net) | $81 | $36 | $13 | $2 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $11 | $0 | $0 | $0 |
| Total NC Assets | $92 | $36 | $13 | $2 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $2,489 | $643 | $961 | $689 |
| Liabilities | – | – | – | – |
| Payables | $391 | $76 | $35 | $30 |
| Short-Term Debt | $519 | $649 | $214 | $255 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $257 | $217 | $209 | $39 |
| Total Curr. Liab. | $1,167 | $943 | $457 | $319 |
| LT Debt | $50 | $9 | $0 | $0 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $0 | $0 | $75 |
| Total NC Liab. | $50 | $9 | $0 | $75 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $0 | $0 | $0 |
| Total Liabilities | $1,217 | $952 | $457 | $394 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $3 | $1 | $1 | $1 |
| Retained Earnings | -$62,149 | -$58,523 | -$55,489 | -$54,392 |
| AOCI | $0 | $0 | $0 | $8 |
| Other Equity | $63,418 | $58,213 | $55,992 | $54,680 |
| Total Equity | $1,271 | -$308 | $503 | $297 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | -$2 |
| Total Liab. & Tot. Equity | $2,489 | $643 | $961 | $689 |
| Net Debt | $520 | $653 | -$172 | $243 |